1 asset in Lymphangioma
Therapeutic assets addressing Lymphangioma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Everolimus Lymphangioma | Yonsei University | P2 | CCC (53) |
Therapeutic assets addressing Lymphangioma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Everolimus Lymphangioma | Yonsei University | P2 | CCC (53) |